Pfizer Inc Asset Turnover Ratio (PFE), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pfizer Inc  (NYSE: PFE)
 

Pfizer Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pfizer Inc's asset turnover ratio has remained unchanged compare to previous quarter at 0.31 in the third quarter (Sep 27 2026)

Within sector 113 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 2624, from total ranking in the second quarter 2026 at 3050.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PFE Asset Turnover Ratio (Sep 27 2026)
III. Quarter		 (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter
Y / Y Asset Change 0.38 % -1.14 % 0.58 % -7.38 % -4.9 %
Y / Y Revenue Change -0.43 % 2.6 % 5.37 % -1.16 % -5.92 %
Asset Turnover Ratio (TTM) 0.31 0.31 0.3 0.3 0.3
PFE's Total Ranking # 2624 # 3050 # 2676 # 2727 # 2811
Seq. Asset Change 2.84 % -2.63 % 0.41 % -0.16 % 1.28 %
Seq. Revenue Change 10.3 % 4.03 % -17.69 % 5.42 % 13.66 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 114
Healthcare Sector # 386
Overall Market # 2624

Asset Turnover Ratio Statistics
High Average Low
0.55 0.35 0.25
(Jul 03 2022)   (Dec 31 2020)




PFE Company Profile • Back to PFE Efficiency Comparisons • Compare PFE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 27 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 27 2026 Assets at quarter ending Sep 27 2026
West Pharmaceutical Services Inc   0.82 $ 3,397.100  Millions$ 4,129.225  Millions
Protalix Biotherapeutics inc   0.82 $ 84.693  Millions$ 103.315  Millions
Incyte Corporation  0.82 $ 6,010.754  Millions$ 7,364.247  Millions
Penumbra Inc  0.81 $ 1,560.334  Millions$ 1,931.196  Millions
Davita Inc   0.80 $ 14,167.545  Millions$ 17,626.367  Millions
Dexcom Inc   0.80 $ 5,104.900  Millions$ 6,416.825  Millions
Amneal Pharmaceuticals Inc   0.79 $ 3,196.184  Millions$ 4,065.517  Millions
Axogen inc   0.78 $ 266.926  Millions$ 341.594  Millions
Labcorp Holdings Inc   0.78 $ 14,594.500  Millions$ 18,734.175  Millions
Iradimed Corporation  0.78 $ 89.340  Millions$ 114.803  Millions
Alector Inc   0.77 $ 173.469  Millions$ 225.446  Millions
Lifestance Health Group Inc   0.77 $ 1,676.889  Millions$ 2,179.399  Millions
Pulmonx Corporation  0.75 $ 89.176  Millions$ 118.550  Millions
Beone Medicines Ltd   0.74 $ 6,606.279  Millions$ 8,948.433  Millions
Arbutus Biopharma Corp  0.74 $ 181.490  Millions$ 246.376  Millions
Msa Safety Inc  0.73 $ 2,015.730  Millions$ 2,749.546  Millions
Adapthealth Corp   0.73 $ 3,152.043  Millions$ 4,320.541  Millions
Neurocrine Biosciences Inc   0.72 $ 3,701.700  Millions$ 5,131.050  Millions
Tenet Healthcare Corp  0.72 $ 22,154.000  Millions$ 30,787.000  Millions
Strata Critical Medical Inc   0.72 $ 236.425  Millions$ 328.668  Millions
Acadia Pharmaceuticals Inc   0.72 $ 1,202.301  Millions$ 1,676.619  Millions
Gossamer Bio Inc   0.71 $ 78.423  Millions$ 110.588  Millions
Quest Diagnostics Inc  0.71 $ 11,841.000  Millions$ 16,764.500  Millions
Mirum Pharmaceuticals Inc   0.71 $ 670.778  Millions$ 951.331  Millions
Ani Pharmaceuticals Inc  0.70 $ 1,041.343  Millions$ 1,481.030  Millions
3m Company  0.68 $ 25,247.000  Millions$ 36,904.750  Millions
Insmed Inc  0.68 $ 1,479.040  Millions$ 2,167.261  Millions
Illumina Inc   0.68 $ 4,538.000  Millions$ 6,666.250  Millions
Dentsply Sirona Inc   0.68 $ 3,575.000  Millions$ 5,263.000  Millions
Biomerica Inc   0.68 $ 4.338  Millions$ 6.413  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.